---
created: '2026-02-13T14:57:58.045833Z'
description: The molecular turbine that synthesizes ATP from ADP and phosphate using
  the proton gradient across the inner mitochondrial membrane. Also known as Complex
  V of the electron transport chain, it is one of nature's most remarkable molecular
  machines.
dg-home: false
dg-publish: true
gardenUsername: dev_admin
permalink: /garden/dev_admin/protein/atp-synthase/
slug: atp-synthase
tags:
- protein
- enzyme
- molecular_motor
- oxidative_phosphorylation
- atp_synthesis
- mitochondrial
templateEngineOverride: njk
title: ATP Synthase
type: protein
updated: '2026-02-13T14:57:58.045833Z'
---

{% raw %}
<h1>ATP Synthase</h1>
<h2>Overview</h2>
<p>ATP synthase (Complex V) is the enzyme responsible for synthesizing the majority of cellular ATP. It is a remarkable molecular machine that uses the proton gradient generated by the electron transport chain to drive the phosphorylation of ADP to ATP.</p>
<p>The enzyme consists of two main portions:</p>
<ul>
<li><strong>F1</strong> (catalytic): Mushroom-shaped head in the matrix</li>
<li><strong>Fo</strong> (proton channel): Membrane-embedded base</li>
</ul>
<p>ATP synthase represents one of the smallest rotary motors in nature, spinning at up to 9,000 rpm and producing approximately 100 ATP molecules per second.</p>
<h2>Structure</h2>
<h3>Fo Portion (Membrane)</h3>
<ul>
<li><strong>a subunit</strong>: Contains proton half-channels</li>
<li><strong>c-ring</strong>: 8-15 c subunits forming a rotating ring</li>
<li><strong>b subunit</strong>: Part of peripheral stalk</li>
<li>Function: Converts proton flow to rotation</li>
</ul>
<h3>F1 Portion (Matrix)</h3>
<ul>
<li><strong>α3β3 hexamer</strong>: Alternating α and β subunits</li>
<li><strong>β subunits</strong>: Contain catalytic sites</li>
<li><strong>γ subunit</strong>: Central rotating shaft</li>
<li><strong>δ/ε subunits</strong>: Coupling between Fo and F1</li>
<li><strong>OSCP</strong>: Part of peripheral stalk</li>
</ul>
<h3>Peripheral Stalk</h3>
<ul>
<li>Connects Fo and F1 non-rotationally</li>
<li>Prevents co-rotation of α3β3 with γ</li>
<li>Essential for coupling</li>
</ul>
<h2>Rotary Catalysis</h2>
<h3>Proton-Driven Rotation</h3>
<ol>
<li>Protons enter from intermembrane space via a subunit half-channel</li>
<li>Protons bind to c subunit carboxyl groups</li>
<li>c-ring rotates as protons are released to matrix</li>
<li>Rotation transmitted to γ subunit</li>
</ol>
<h3>Binding Change Mechanism (Paul Boyer)</h3>
<p>The three β subunits cycle through three conformational states:</p>
<ol>
<li><strong>Open (O)</strong>: Low substrate affinity, releases ATP</li>
<li><strong>Loose (L)</strong>: Binds ADP + Pi loosely</li>
<li><strong>Tight (T)</strong>: Substrates bound tightly, catalysis occurs</li>
</ol>
<p><strong>120° rotation converts each site to next state</strong></p>
<h3>ATP Synthesis</h3>
<ul>
<li>Each 360° rotation: 3 ATP synthesized</li>
<li>H⁺/ATP ratio: ~3-4 protons per ATP</li>
<li>Efficiency: ~40% (comparable to combustion engines)</li>
</ul>
<h2>Energetics</h2>
<h3>Proton Motive Force</h3>
<ul>
<li>ΔG for ATP synthesis: +30.5 kJ/mol</li>
<li>Requires ~3-4 protons (10-13 kJ/mol each)</li>
<li>Proton gradient provides driving force</li>
</ul>
<h3>Reversibility</h3>
<ul>
<li>ATP synthase can run in reverse</li>
<li>Hydrolyzes ATP to pump protons</li>
<li>Occurs during ischemia (wastes ATP)</li>
<li>IF1 protein inhibits reverse mode</li>
</ul>
<h2>Regulation</h2>
<h3>Inhibitory Factor 1 (IF1)</h3>
<ul>
<li>Prevents ATP hydrolysis during hypoxia</li>
<li>Active at low pH (ischemia)</li>
<li>Protects ATP stores</li>
</ul>
<h3>Ca²⁺ Regulation</h3>
<ul>
<li>Ca²⁺ enhances ATP synthase activity</li>
<li>Coordinates with TCA cycle activation</li>
<li>Important in muscle and neurons</li>
</ul>
<h3>Membrane Potential</h3>
<ul>
<li>Activity depends on proton motive force</li>
<li>Uncouplers dissipate gradient, stop synthesis</li>
<li>Critical for metabolic flexibility</li>
</ul>
<h2>Inhibitors</h2>
<table>
<thead>
<tr>
<th>Inhibitor</th>
<th>Mechanism</th>
</tr>
</thead>
<tbody>
<tr>
<td>Oligomycin</td>
<td>Blocks proton channel in Fo</td>
</tr>
<tr>
<td>DCCD</td>
<td>Covalently modifies c subunit</td>
</tr>
<tr>
<td>Aurovertin</td>
<td>Binds β subunit</td>
</tr>
<tr>
<td>Efrapeptin</td>
<td>Binds F1</td>
</tr>
</tbody>
</table>
<h2>Clinical Significance</h2>
<h3>Mitochondrial Diseases</h3>
<ul>
<li>ATP synthase deficiency (rare but severe)</li>
<li>ATP6 mutations (mtDNA-encoded)</li>
<li>Neuropathy, ataxia, retinitis pigmentosa (NARP)</li>
<li>Leigh syndrome</li>
</ul>
<h3>Ischemia-Reperfusion</h3>
<ul>
<li>Reverse mode wastes ATP during ischemia</li>
<li>IF1 provides some protection</li>
<li>Therapeutic target for cardioprotection</li>
</ul>
<h3>Cancer</h3>
<ul>
<li>Altered ATP synthase in some cancers</li>
<li>IF1 overexpression in some tumors</li>
<li>Metabolic adaptation to hypoxia</li>
</ul>
<h3>Aging</h3>
<ul>
<li>ATP synthase activity declines with age</li>
<li>Contributes to mitochondrial dysfunction</li>
<li>Assembly defects accumulate</li>
</ul>
<h2>Drug/Supplement Connections</h2>
<table>
<thead>
<tr>
<th>Agent</th>
<th>Effect</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Oligomycin</strong></td>
<td>Inhibitor (research)</td>
</tr>
<tr>
<td><strong><a class="internal-link is-unresolved" href="/404">CoQ10</a></strong></td>
<td>Supports upstream ETC</td>
</tr>
<tr>
<td><strong><a href="/garden/dev_admin/supplement/nmn/" class="internal-link">NMN</a>/<a href="/garden/dev_admin/supplement/nicotinamide-riboside/" class="internal-link">Nicotinamide Riboside</a></strong></td>
<td>Supports NAD+ → NADH → ETC → protons</td>
</tr>
<tr>
<td><strong><a href="/garden/dev_admin/supplement/creatine/" class="internal-link">Creatine</a></strong></td>
<td>Buffers ATP produced</td>
</tr>
<tr>
<td><strong><a href="/garden/dev_admin/supplement/magnesium/" class="internal-link">Magnesium</a></strong></td>
<td>Required for ATP (MgATP substrate)</td>
</tr>
</tbody>
</table>
<h2>Nobel Prize Recognition</h2>
<ul>
<li><strong>1978</strong>: Peter Mitchell (chemiosmotic theory)</li>
<li><strong>1997</strong>: Paul Boyer, John Walker (ATP synthase mechanism)
<ul>
<li>Boyer: Binding change mechanism</li>
<li>Walker: High-resolution structure</li>
</ul>
</li>
</ul>
<!-- NEO4J_CONTENT_START -->
<h2>Relationships</h2>
<h3>Related</h3>
<ul>
<li>→ <a href="/garden/dev_admin/supplement/nicotinamide-riboside/" class="internal-link">Nicotinamide_Riboside</a> (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:48:59.343642'
source: obsidian
</code></pre>
<ul>
<li>→ <a href="/garden/dev_admin/cellularcomponent/mitochondria/" class="internal-link">Mitochondria</a> (cellularcomponent)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:48:59.343642'
source: obsidian
</code></pre>
<ul>
<li>→ <a class="internal-link is-unresolved" href="/404">CoQ10</a> (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:29.174663'
source: obsidian
</code></pre>
<ul>
<li>← <a href="/garden/dev_admin/cellularcomponent/mitochondria/" class="internal-link">Mitochondria</a> (cellularcomponent)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:19.549791'
source: obsidian
</code></pre>
<ul>
<li>→ <a href="/garden/dev_admin/supplement/nicotinamide-riboside/" class="internal-link">Nicotinamide_Riboside</a> (metabolite)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:29.174663'
source: obsidian
</code></pre>
<ul>
<li>→ <a href="/garden/dev_admin/supplement/creatine/" class="internal-link">Creatine</a> (drug)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:29.174663'
source: obsidian
</code></pre>
<ul>
<li>→ <a href="/garden/dev_admin/supplement/magnesium/" class="internal-link">Magnesium</a> (supplement)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:29.174663'
source: obsidian
</code></pre>
<ul>
<li>→ <a href="/garden/dev_admin/supplement/nmn/" class="internal-link">NMN</a> (supplement)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:29.174663'
source: obsidian
</code></pre>
<!-- NEO4J_CONTENT_END -->
<h2>Relationships</h2>
<p>LOCATED_IN::<a href="/garden/dev_admin/cellularcomponent/mitochondria/" class="internal-link">Mitochondria</a> - Inner membrane<br />
PRODUCES::<a class="internal-link is-unresolved" href="/404">ATP</a> - Primary product<br />
CONSUMES::<a class="internal-link is-unresolved" href="/404">ADP</a> - Substrate<br />
CONSUMES::<a class="internal-link is-unresolved" href="/404">Phosphate</a> - Substrate<br />
DRIVEN_BY::<a class="internal-link is-unresolved" href="/404">Proton Gradient</a> - Chemiosmotic coupling<br />
PART_OF::<a href="/garden/dev_admin/pathway/electron-transport-chain/" class="internal-link">Electron Transport Chain</a> - Complex V<br />
PART_OF::<a href="/garden/dev_admin/pathway/oxidative-phosphorylation/" class="internal-link">Oxidative Phosphorylation</a> - ATP synthesis step<br />
INHIBITED_BY::<a class="internal-link is-unresolved" href="/404">Oligomycin</a> - Research tool<br />
SUPPORTED_BY::<a class="internal-link is-unresolved" href="/404">CoQ10</a> - Via ETC function<br />
SUPPORTED_BY::<a href="/garden/dev_admin/supplement/magnesium/" class="internal-link">Magnesium</a> - MgATP formation<br />
REGULATED_BY::<a class="internal-link is-unresolved" href="/404">IF1</a> - Prevents ATP hydrolysis<br />
RELATED_TO::<a class="internal-link is-unresolved" href="/404">NADH</a> - Upstream electron donor<br />
RELATED_TO::<a class="internal-link is-unresolved" href="/404">Oxygen</a> - Terminal electron acceptor</p>
<h2>References</h2>
<ul>
<li>Boyer PD. The ATP synthase—a splendid molecular machine. Annu Rev Biochem. 1997;66:717-49. PMID: 9242922</li>
<li>Walker JE. The ATP synthase: the understood, the uncertain and the unknown. Biochem Soc Trans. 2013;41(1):1-16. PMID: 23356252</li>
<li>Jonckheere AI, et al. Mitochondrial ATP synthase: architecture, function and pathology. J Inherit Metab Dis. 2012;35(2):211-25. PMID: 21874297</li>
</ul>

{% endraw %}